Groups

Parametersa

Control

Doxorubicin

Doxorubicin + stem cells

Doxorubicin + C. sinensis

Body weight (g)

264.8(31.1)

133.3(22.0)*

203.0(54.8)*†

117.3(28.7)*

Hw / Bw ratio (x103)

3.9(0.4)

4.7(0.1)*

3.5(0.6)

5.3(0.8)*

RBC (x106/µl)

6.1(0.6)

6.9(2.4)

5.9(0.3)

5.7(0.1)

WBC (x103/µl)

6.3(3.4)

7.2(5.5)

5.8(3.6)

8.7(3.3)

CK (U/l)

1565(2291)

1079(439)

1103(300)

949(648)

CK-MB (U/l)

752(675)

619(90)

536(466)

528(530)

LDH (U/l)

755(650)

625(465)

814(207)

448(357)

Urea (mg/dl)

54(9)

40(15)

22(18)

39(3)

Creatinine (mg/dl)

0.5(0.04)

1.7(2.2)

0.7(0.5)

0.5(0.06)
aHw / Bw ratio: heart weight/body weight ratio; RBC: red blood cell count; WBC: white blood cell count; CK: creatine kinase; CK-MB: creatine kinase isoenzyme; LDH: lactate dehydrogenase; * p < 0.05 vs. Control; † p < 0.05 vs. Doxorubicin
Table 1: Body weight, heart weight/body weight ratio, hematological, and serum biochemical parameters [mean (standard deviation)] obtained from Wistar rats by the end of the experimental period.